Brain and Cardiometabolic Effects of Major Weight Loss in People With Obesity: Preliminary Cohort Findings
Open Access
- 30 October 2026
- journal article
- Published by Wiley in Obesity Science & Practice
- Vol. 12 (6)
Abstract
Objective: Given the overlap between obesity‐related metabolic and vascular abnormalities and Alzheimer's disease (AD) risk factors, it is critical to determine whether weight loss improves brain and cardiovascular health. This study examined whether ≥ 40% excess‐weight loss is associated with improvements in cardiometabolic risk, brain structure, and cognition. Methods: The study was a longitudinal study of individuals with obesity undergoing metabolic and bariatric surgery or medical/behavioral weight‐loss treatment. Participants were classified at follow‐up as weight‐loss (WL; ≥ 40% excess‐weight loss) or non‐weight‐loss (nWL; < 40%). All completed medical evaluations, structural MRI, and cognitive testing at baseline and 1 year. Results: At 1 year, the WL group exhibited improvements in BMI, HbA1C, inflammatory, metabolic, and lipid profiles. MRI‐based volumetrics revealed increases in subcortical gray‐matter volume and preservation of AD‐vulnerable regions. Cognitive performance remained unchanged. Conclusions: Achieving ≥ 40% excess‐weight loss was associated with improvements in metabolic health and brain structure, including favorable subcortical volume increases. These findings underscore the potential of sustained weight reduction to mitigate risks linked to metabolic syndromes and neurodegeneration. Longer‐term follow‐up is warranted to determine whether continued metabolic improvements lead to detectable cognitive gains and additional brain‐health benefits beyond 1 year.Keywords
Funding Information
- National Institutes of Health (R01AG055624)
- National Institutes of Health (R01 AG056031)
- National Institutes of Health (R01 AG056531)
- National Institutes of Health (R01 AG056682)
- National Institutes of Health (R01 AG068248)
- National Institutes of Health (R01 AG070821)
- National Institutes of Health (R01 AG079282)
- National Institutes of Health (R01 AG080609)
- National Institutes of Health (RF1AG080609)
This publication has 29 references indexed in Scilit:
- GLP-1 Medications May Lower Dementia Risk, Research ShowsJAMA, 2025
- Longitudinal Analysis of Obesity Drug Use and Public AwarenessJAMA Network Open, 2025
- Brain microvascular injury and white matter disease provoked by diabetes‐associated hyperamylinemiaAnnals of Neurology, 2017
- The role of insulin in the vascular contributions to age-related dementiaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016
- Is 5% weight loss a satisfactory criterion to define clinically significant weight loss?Obesity, 2015
- Preliminary evidence of cognitive and brain abnormalities in uncomplicated adolescent obesityObesity, 2014
- Magnetic Resonance Relaxation and Quantitative Measurement in the Brain2010
- Brain structure and obesityHuman Brain Mapping, 2009
- Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitusBrain Research, 2009
- Elevated C-Reactive Protein Levels in Overweight and Obese AdultsJAMA, 1999